Overactive Bladder - Results from #80

Feasibility and clinical implications of 3-day bladder diary derived classification of female storage lower urinary tract symptoms. November 27, 2022

Urobiome changes differ based on OAB treatment in adult females. November 27, 2022

Comparison of different types of therapy for overactive bladder: A systematic review and network meta-analysis. November 27, 2022

Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial. November 20, 2022

Quality of life and sexual function evaluation in women with urogynecological diseases analyzed with telemedicine during the Covid period: the beginning of a new era? November 20, 2022

Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review. November 20, 2022

Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season November 14, 2022

Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review. November 13, 2022

Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France? November 13, 2022

Quality of life and psychological aspects in children with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation - A prospective multicenter study. November 13, 2022

Bullseye Technique to Optimize S3 Foramen Access: Applying a Trusted Endourology Technique to Pelvic Medicine. November 13, 2022

Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study. November 13, 2022

Evaluation of Overactive Bladder Symptoms in Patients Recovering from Post-Acute COVID-19 Syndrome. November 6, 2022

Are β3 -adrenoceptor gene polymorphisms relevant for urology? November 6, 2022

The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder. October 30, 2022

Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms. October 30, 2022

Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis. October 30, 2022

Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study. October 23, 2022

Treatment for overactive bladder: A meta-analysis of tibial versus parasacral neuromodulation. October 23, 2022

Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital. October 23, 2022

Page 5 of 109

SUFU MyBladder app